Literature DB >> 6414742

Carbonic anhydrase III in Duchenne muscular dystrophy.

N D Carter, R Heath, S Jeffery, M J Jackson, D J Newham, R H Edwards.   

Abstract

Plasma carbonic anhydrase III (CAIII) levels determined by radioimmunoassay have been compared, in detail, with creatine kinase (CK) as indices of Duchenne muscular dystrophy (DMD). CAIII levels were markedly elevated in all patients but variability of levels in a number of individual patients was higher than CK.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6414742     DOI： 10.1016/0009-8981(83)90405-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


  8 in total

1.  Serum carbonic anhydrase III, an enzyme of type I muscle fibres, and the intensity of physical exercise.

Authors:  T E Takala; P Rahkila; E Hakala; J Vuori; J Puranen; K Väänänen
Journal:  Pflugers Arch       Date:  1989-03       Impact factor: 3.657

2.  Purification and localization of human carbonic anhydrase. III. Typing of skeletal muscle fibers in paraffin embedded sections.

Authors:  H K Väänänen; M Paloniemi; J Vuori
Journal:  Histochemistry       Date:  1985

3.  Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies.

Authors:  Burcu Ayoglu; Amina Chaouch; Hanns Lochmüller; Luisa Politano; Enrico Bertini; Pietro Spitali; Monika Hiller; Eric H Niks; Francesca Gualandi; Fredrik Pontén; Kate Bushby; Annemieke Aartsma-Rus; Elena Schwartz; Yannick Le Priol; Volker Straub; Mathias Uhlén; Sebahattin Cirak; Peter A C 't Hoen; Francesco Muntoni; Alessandra Ferlini; Jochen M Schwenk; Peter Nilsson; Cristina Al-Khalili Szigyarto
Journal:  EMBO Mol Med       Date:  2014-07       Impact factor: 12.137

4.  Cathepsin A inhibition attenuates myocardial infarction-induced heart failure on the functional and proteomic levels.

Authors:  Agnese Petrera; Johann Gassenhuber; Sven Ruf; Deepika Gunasekaran; Jennifer Esser; Jasmin Hasmik Shahinian; Thomas Hübschle; Hartmut Rütten; Thorsten Sadowski; Oliver Schilling
Journal:  J Transl Med       Date:  2016-05-31       Impact factor: 5.531

5.  Proteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy.

Authors:  Sandra Murphy; Paul Dowling; Margit Zweyer; Michael Henry; Paula Meleady; Rustam R Mundegar; Dieter Swandulla; Kay Ohlendieck
Journal:  Int J Mol Med       Date:  2017-04-18       Impact factor: 4.101

Review 6.  Biomarkers of Duchenne muscular dystrophy: current findings.

Authors:  Cristina Al-Khalili Szigyarto; Pietro Spitali
Journal:  Degener Neurol Neuromuscul Dis       Date:  2018-01-25

7.  Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients.

Authors:  Daniele Capitanio; Manuela Moriggi; Enrica Torretta; Pietro Barbacini; Sara De Palma; Agnese Viganò; Hanns Lochmüller; Francesco Muntoni; Alessandra Ferlini; Marina Mora; Cecilia Gelfi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-01-28       Impact factor: 12.910

Review 8.  Caenorhabditis elegans as a Model System for Duchenne Muscular Dystrophy.

Authors:  Rebecca A Ellwood; Mathew Piasecki; Nathaniel J Szewczyk
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 6.208
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.